179 related articles for article (PubMed ID: 33070889)
41. Surgery for epilepsy.
West S; Nevitt SJ; Cotton J; Gandhi S; Weston J; Sudan A; Ramirez R; Newton R
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD010541. PubMed ID: 31237346
[TBL] [Abstract][Full Text] [Related]
42. Surgical outcome and predictive factors of epilepsy surgery in pediatric isolated focal cortical dysplasia.
Choi SA; Kim SY; Kim H; Kim WJ; Kim H; Hwang H; Choi JE; Lim BC; Chae JH; Chong S; Lee JY; Phi JH; Kim SK; Wang KC; Kim KJ
Epilepsy Res; 2018 Jan; 139():54-59. PubMed ID: 29197666
[TBL] [Abstract][Full Text] [Related]
43. [Analysis of the cost-effectiveness of treatment for refractory partial epilepsy: a simulation model for pregabalin and levetiracetam].
Díaz S; Argumosa A; Horga de la Parte JF; Vera-Llonch M; Dukes E; Rejas-Gutiérrez J
Rev Neurol; 2007 Oct 16-31; 45(8):460-7. PubMed ID: 17948211
[TBL] [Abstract][Full Text] [Related]
44. The direct cost of seizure events in severe childhood-onset epilepsies: A retrospective claims-based analysis.
Reaven NL; Funk SE; Lyons PD; Story TJ
Epilepsy Behav; 2019 Apr; 93():65-72. PubMed ID: 30831405
[TBL] [Abstract][Full Text] [Related]
45. Lacosamide as a first-line treatment option in focal epilepsy: a cost-utility analysis for the Greek healthcare system.
Geitona M; Stamuli E; Giannakodimos S; Kimiskidis VK; Kountouris V; Charokopou M; Christou P
J Med Econ; 2019 Apr; 22(4):359-364. PubMed ID: 30652931
[TBL] [Abstract][Full Text] [Related]
46. Establishment of low cost epilepsy surgery centers in resource poor setting.
Jukkarwala A; Baheti NN; Dhakoji A; Salgotra B; Menon G; Gupta A; Prakash S; Rathore C
Seizure; 2019 Jul; 69():245-250. PubMed ID: 31121549
[TBL] [Abstract][Full Text] [Related]
47. The effectiveness and safety of lacosamide in children with epilepsy in a clinical practice setting.
Sanmartí-Vilaplana F; Díaz-Gómez A
Epilepsy Behav; 2018 Feb; 79():130-137. PubMed ID: 29287216
[TBL] [Abstract][Full Text] [Related]
48. Cost-effectiveness analysis of responsive neurostimulation for drug-resistant focal onset epilepsy.
Youngerman BE; Mahajan UV; Dyster TG; Srinivasan S; Halpern CH; McKhann GM; Sheth SA
Epilepsia; 2021 Nov; 62(11):2804-2813. PubMed ID: 34458986
[TBL] [Abstract][Full Text] [Related]
49. Cost-effectiveness analysis of pharmacogenetic-guided warfarin dosing in Thailand.
Chong HY; Saokaew S; Dumrongprat K; Permsuwan U; Wu DB; Sritara P; Chaiyakunapruk N
Thromb Res; 2014 Dec; 134(6):1278-84. PubMed ID: 25456732
[TBL] [Abstract][Full Text] [Related]
50. Cost-effectiveness of Corticosteroid Nasal Spray vs Surgical Therapy in Patients With Severe to Extreme Anatomical Nasal Obstruction.
Teti VP; Akdagli S; Most SP
JAMA Facial Plast Surg; 2016 May; 18(3):165-70. PubMed ID: 26747790
[TBL] [Abstract][Full Text] [Related]
51. Economic evaluation of levetiracetam as an add-on therapy in patients with refractory epilepsy.
Blais L; Sheehy O; St-Hilaire JM; Bernier G; Godfroid P; LeLorier JJ
Pharmacoeconomics; 2005; 23(5):493-503. PubMed ID: 15896100
[TBL] [Abstract][Full Text] [Related]
52. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
53. [Children with drug-resistant partial epilepsy: criteria for the identification of surgical candidates].
Hirsch E; Arzimanoglou A
Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S210-9. PubMed ID: 15331969
[TBL] [Abstract][Full Text] [Related]
54. Socioeconomic outcome of epilepsy surgery: A controlled national study.
Jennum P; Sabers A; Christensen J; Ibsen R; Kjellberg J
Seizure; 2016 Nov; 42():52-56. PubMed ID: 27770730
[TBL] [Abstract][Full Text] [Related]
55. A comparison of surgical and medical costs for refractory epilepsy.
Platt M; Sperling MR
Epilepsia; 2002; 43 Suppl 4():25-31. PubMed ID: 12059998
[No Abstract] [Full Text] [Related]
56. Cost effectiveness of rituximab and mycophenolate mofetil for neuromyelitis optica spectrum disorder in Thailand: Economic evaluation and budget impact analysis.
Aungsumart S; Apiwattanakul M
PLoS One; 2020; 15(2):e0229028. PubMed ID: 32050011
[TBL] [Abstract][Full Text] [Related]
57. Advances in the Surgical Management of Epilepsy: Drug-Resistant Focal Epilepsy in the Adult Patient.
Cascino GD; Brinkmann BH
Neurol Clin; 2021 Feb; 39(1):181-196. PubMed ID: 33223082
[TBL] [Abstract][Full Text] [Related]
58. Cost-effectiveness of pharmacist-participated warfarin therapy management in Thailand.
Saokaew S; Permsuwan U; Chaiyakunapruk N; Nathisuwan S; Sukonthasarn A; Jeanpeerapong N
Thromb Res; 2013 Oct; 132(4):437-43. PubMed ID: 24041634
[TBL] [Abstract][Full Text] [Related]
59. A multicenter, matched case-control analysis comparing burden-of-illness in Dravet syndrome to refractory epilepsy and seizure remission in patients and caregivers in Germany.
Strzelczyk A; Schubert-Bast S; Bast T; Bettendorf U; Fiedler B; Hamer HM; Herting A; Kalski M; Kay L; Kieslich M; Klein KM; Kluger G; Kurlemann G; Mayer T; Neubauer BA; Polster T; von Spiczak S; Stephani U; Trollmann R; Wiemer-Kruel A; Wolff M; Irwin J; Carroll J; Pritchard C; Rosenow F
Epilepsia; 2019 Aug; 60(8):1697-1710. PubMed ID: 31247127
[TBL] [Abstract][Full Text] [Related]
60. Long-term outcomes of epilepsy surgery in school-aged children with partial epilepsy.
Liang S; Wang S; Zhang J; Ding C; Zhang Z; Fu X; Hu X; Meng X; Jiang H; Zhang S
Pediatr Neurol; 2012 Oct; 47(4):284-90. PubMed ID: 22964443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
